Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFINE trial of roxadustat for renal anemia in non-dialysis patients with lower extremity artery disease
jRCTs031230506Recruiting
- Sponsor
- Astellas Pharma
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of roxadustat in anemia of chronic kidney disease (2 arms), sponsored by Astellas Pharma. Primary endpoint: Change in hemoglobin level from baseline to 24 weeks after randomization. Started Apr 2024; status: recruiting.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on jRCTs031230506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230506.